Ben Sidders | CSO
Biorelate
Dr Ben Sidders, Chief Scientific Officer at Biorelate, has been working at the forefront of pharma data science for the last two decades. Formerly Executive Director and Head of Early Data Science within Oncology R&D at AstraZeneca, responsible for advancing the company’s understanding of disease through computational oncology, Ben also previously spent eight years at Pfizer, and has extensive experience of many aspects of drug discovery for major pharma.
Appearances:
BioTechX Europe Day 1 @ 14:50
Agentic AI and large language models: Tapping into new drug discovery possibilities
Discover how new agentic artificial intelligence (AI) and large language model (LLM) technologies will enable researchers to get a complete understanding of the regulatory network between biomedical entities from the literature alone. This talk dives into exciting case studies for how new agentic frameworks elevate AI's ability to provide reliable, deep answers to key scientific questions during the drug discovery process, for example when describing mechanistic rationale during target discovery/selection.
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events